Essential Pharmaceuticals is honored to have been chosen as a finalist for the prestigious Great Oak Awards. The Great Oak Awards honors NJ’s most generous companies.
Along with our charitable contributions, the criteria of such a standing is to be sturdy, solid and capable of impressive growth while being able to bend and change with times.
We are humbled and accept this nomination.
PRESS RELEASE — EWING, NJ. April 6, 2016—Essential Pharmaceuticals LLC, Celebrates 10th Anniversary as a leader in the organ transplant solution market and biopharmaceutical production and medical research. Read the statement from CEO Allan Weber.
Recent Study by Dr. Konstandinos A Plestis, Chief of Cardiothoracic and Vascular Surgery, Thomas Jefferson University
Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Technique
John Fung, MD, PhD, a pioneer transplant surgeon and newly named Director of the Cleveland Clinic Health System Center for Transplantation recently received the 2015 Thomas E. Starzl Prize in Surgery and Immunology in May.
The Thomas E. Starzl Transplantation Institute and Department of Surgery at the University of Pittsburgh Medical Center (UPMC) award the prize annually to an international leader in organ transplantation. Read More…
Dr John Fung recently presented on Organ Preservation Solutions at the ESOT congress. Below is his presentation is two parts.
Essential Matters Blog
- Essential Pharma named finalist in NJ Business of the Year!!!!
- Essential Pharmaceuticals, LLC and Dr. Adam Elhofy Chosen to Present at the 2016 Bioprocessing Summit
- Two Years ago we moved to NJ!
- Essential Pharmaceuticals launches new streamlined website & online ordering system for bioproduction and research products